Cargando…
A Systematic Review of Magnesium Sulfate for Perinatal Neuroprotection: What Have We Learnt From the Past Decade?
There is an important unmet need to improve long term outcomes of encephalopathy for preterm and term infants. Meta-analyses of large controlled trials suggest that maternal treatment with magnesium sulfate (MgSO(4)) is associated with a reduced risk of cerebral palsy and gross motor dysfunction aft...
Autores principales: | Galinsky, Robert, Dean, Justin M., Lingam, Ingran, Robertson, Nicola J., Mallard, Carina, Bennet, Laura, Gunn, Alistair J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7267212/ https://www.ncbi.nlm.nih.gov/pubmed/32536903 http://dx.doi.org/10.3389/fneur.2020.00449 |
Ejemplares similares
-
Glia and hemichannels: key mediators of perinatal encephalopathy
por: Galinsky, Robert, et al.
Publicado: (2018) -
Interleukin-1: an important target for perinatal neuroprotection?
por: Kelly, Sharmony B., et al.
Publicado: (2022) -
Role of magnesium sulfate in neuroprotection in acute ischemic stroke
por: Singh, Harpreet, et al.
Publicado: (2012) -
Magnesium sulfate and fetal neuroprotection: overview of clinical evidence
por: Chollat, Clément, et al.
Publicado: (2018) -
A systematic review of immune-based interventions for perinatal neuroprotection: closing the gap between animal studies and human trials
por: Kelly, Sharmony B., et al.
Publicado: (2023)